Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells

被引:223
作者
Dong, M
Richards, DA
Goodnough, MC
Tepp, WH
Johnson, EA
Chapman, ER
机构
[1] Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA
[2] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA
[3] Univ Wisconsin, Dept Food Microbiol & Toxicol, Madison, WI 53706 USA
[4] Metabiol Inc, Madison, WI 53719 USA
关键词
synaptotagmin; synaptobrevin; clostridial neurotoxin; neurotoxin receptor; gangliosides;
D O I
10.1083/jcb.200305098
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Botulinum neurotoxins (BoNTs) cause botulism by entering neurons and cleaving proteins that mediate neurotransmitter release; disruption of exocytosis results in paralysis and death. The receptors for BoNTs are thought to be composed of both proteins and gangliosides; however, protein components that mediate toxin entry have not been identified. Using gain-of-function and loss-of-function approaches, we report here that the secretory vesicle proteins, synaptotagmins (syts) I and II, mediate the entry of BoNT/B (but not BoNT/A or E) into PC12 cells. Further, we demonstrate that BoNT/B entry into PC12 cells and rat diaphragm motor nerve terminals was activity dependent and can be blocked using fragments of syt II that contain the BoNT/B-binding domain. Finally, we show that syt II fragments, in conjunction with gangliosides, neutralized BoNT/B in intact mice. These findings establish that syts I and II can function as protein receptors for BoNT/B.
引用
收藏
页码:1293 / 1303
页数:11
相关论文
共 46 条
[1]   Botulinum toxin as a biological weapon - Medical and public health management [J].
Arnon, SS ;
Schechter, R ;
Inglesby, TV ;
Henderson, DA ;
Bartlett, JG ;
Ascher, MS ;
Eitzen, E ;
Fine, AD ;
Hauer, J ;
Layton, M ;
Lillibridge, S ;
Osterholm, MT ;
O'Toole, T ;
Parker, G ;
Perl, TM ;
Russell, PK ;
Swerdlow, DL ;
Tonat, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (08) :1059-1070
[2]   Membrane-embedded synaptotagmin penetrates cis or trans target membranes and clusters via a novel mechanism [J].
Bai, JH ;
Earles, CA ;
Lewis, JL ;
Chapman, ER .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (33) :25427-25435
[3]   BOTULINUM NEUROTOXIN-A SELECTIVELY CLEAVES THE SYNAPTIC PROTEIN SNAP-25 [J].
BLASI, J ;
CHAPMAN, ER ;
LINK, E ;
BINZ, T ;
YAMASAKI, S ;
DECAMILLI, P ;
SUDHOF, TC ;
NIEMANN, H ;
JAHN, R .
NATURE, 1993, 365 (6442) :160-163
[4]  
BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x
[5]   STATISTICAL ANALYSIS OF A RAPID IN VIVO METHOD FOR TITRATION OF TOXIN OF CLOSTRIDIUM BOTULINUM [J].
BOROFF, DA ;
FLECK, U .
JOURNAL OF BACTERIOLOGY, 1966, 92 (05) :1580-&
[6]  
Bullens RWM, 2002, J NEUROSCI, V22, P6876
[7]   A novel function for the second C2 domain of synaptotagmin - Ca2+-triggered dimerization [J].
Chapman, ER ;
An, S ;
Edwardson, JM ;
Jahn, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (10) :5844-5849
[8]   Synaptotagmin:: A Ca2+ sensor that triggers exocytosis? [J].
Chapman, ER .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (07) :498-508
[9]  
DASGUPTA BR, 1970, BIOCHIM BIOPHYS ACTA, V214, P343
[10]   ACCEPTORS FOR BOTULINUM NEUROTOXIN RESIDE ON MOTOR-NERVE TERMINALS AND MEDIATE ITS INTERNALIZATION [J].
DOLLY, JO ;
BLACK, J ;
WILLIAMS, RS ;
MELLING, J .
NATURE, 1984, 307 (5950) :457-460